Dianthus Therapeutics, Inc. (DNTH) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$5,031
Total Return
-49.69%
CAGR
-12.84%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.33% |
| Median | -0.26% |
| Best | +136.99% |
| Worst | -74.84% |
| % of Windows Positive | 48.6% |
1-Year (252 Trading Days)
| Average | +20.25% |
| Median | -19.94% |
| Best | +508.39% |
| Worst | -92.94% |
| % of Windows Positive | 44.5% |
3-Year (756 Trading Days)
| Average | +52.60% |
| Median | -40.39% |
| Best | +712.59% |
| Worst | -89.70% |
| % of Windows Positive | 33.9% |
Risk Metrics
| Maximum Drawdown | -97.21% |
| Average Drawdown | -80.10% |
| Drawdown Duration | 1226 Trading Days (Unrecovered) |
| Sortino Ratio | 0.47 |
| Calmar Ratio | -0.13 |
| CVaR (5%) | -11.03% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +118.76% (+1214.19% ann.) | +$11875.69 | $0.00 | $0.00 | $0.00 |
| 2025 | +89.04% | +$8903.73 | $0.00 | $0.00 | $0.00 |
| 2024 | +109.61% | +$10961.44 | $0.00 | $0.00 | $0.00 |
| 2023 | +62.50% | +$6250.18 | $0.00 | $0.00 | $0.00 |
| 2022 | -90.97% | $9097.07 | $0.00 | $0.00 | $0.00 |
| 2021 | -43.49% | $4349.50 | $0.00 | $0.00 | $0.00 |
| 2020 | -48.28% | $4828.49 | $0.00 | $0.00 | $0.00 |
| 2019 | +165.96% | +$16596.49 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -60.74% (-82.96% ann.) | $6074.38 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 21, 2018 – February 19, 2020 | -10.19% | -6.25% | $1019.28 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -56.20% | -99.99% | $5620.13 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +0.48% | +0.77% | +$47.84 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -6.23% | -5.92% | $622.96 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -80.64% | -82.51% | $8063.94 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +54.70% | +26.54% | +$5470.31 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +246.73% | +118.80% | +$24672.92 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.